Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: Progress towards elimination of a health disparity

Vaccine

Volumn 23, Issue 48-49, 2005, Pages 5464-5473

  Hennessy, Thomas W ^a   Singleton, Rosalyn J ^b   Bulkow, Lisa R ^a   Bruden, Dana L ^a   Hurlburt, Debby A ^a   Parks, Debra ^a   Moore, Matthew ^a   Parkinson, Alan J ^a   Schuchat, Anne ^a   Butler, Jay C ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

Author keywords

Alaska Natives; Antimicrobial resistance; Conjugate vaccine; Disease prevention; Nasopharyngeal colonization; Pediatric vaccine; Pneumococcal disease; Streptococcus pneumoniae; Surveillance

Indexed keywords

CEFOTAXIME; COTRIMOXAZOLE; ERYTHROMYCIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; PENICILLIN G; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; EVALUATION; HEALTH SURVEY; HUMAN; MICROBIAL COLONIZATION; NASOPHARYNX; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; RURAL AREA; STREPTOCOCCUS INFECTION; UNITED STATES; URBAN AREA;

ADOLESCENT; ADULT; ALASKA; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MENINGOCOCCAL VACCINES; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE;

EID: 27744482562     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.08.100     Document Type: Conference Paper

References (39)

1. M. Davidson, A.J. Parkinson, L.R. Bulkow, M.A. Fitzgerald, H.V. Peters, and D.J. Parks The epidemiology of invasive pneumococcal disease in Alaska, 1986-1990 - ethnic differences and opportunities for prevention J Infect Dis 170 2 1994 368 376 comment
2. K.M. Rudolph, A.J. Parkinson, A.L. Reasonover, L.R. Bulkow, D.J. Parks, and J.C. Butler Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991-1998 J Infect Dis 182 2 2000 490 496
3. C.G. Whitney, M.M. Farley, J. Hadler, L.H. Harrison, N.M. Bennett, and R. Lynfield Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine N Engl J Med 348 18 2003 1737 1746
4. D. Wolsey, and J.E. Cheek Epidemiologic patterns of morbidity and mortality J. Galloway B. Goldberg J. Alpert Primary care of Native American patients 1999 Butterworth Heinemann Boston 7 16
5. Middaugh JP, Miller JL, Dunaway CE, Jenkerson SA, Kelly T, Ingle D, et al. Causes of Death in Alaska, 1950, 1980-1989. Anchorage: State of Alaska; 1991.
6. S.F. Dowell, J.C. Butler, and G.S. Giebink Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group Pediatr Infect Dis J 18 1999 1 9
7. S. Black, H. Shinefield, B. Fireman, E. Lewis, P. Ray, and J.R. Hansen Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group Pediatr Infect Dis J 19 3 2000 187 195 [comment]
8. S.B.S.H. Black, J. Hansen, L. Elvin, D. Luafer, and F. Malinoski Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine Pediatr Infect Dis J 20 12 2001 1105 1107
9. R.R. Ramani, W.N. Hall, M. Boulton, D.R. Johnson, and B. Zhu Impact of PCV7 on invasive pneumocccal disease among children younger than 5 years: a population-based study Am J Public Health 94 6 2004 958 959
10. P.L. Lin, M.G. Michaels, J. Janosky, M. Ortenzo, and E.R. Wald Incidence of invasive pneumococcal disease in children 3 to 36 months of age at a tertiary care pediatric center 2 years after licensure of the pneumcoccal conjugate vaccine Pediatrics 111 4 2003 896 899
11. R. Dagan, N. Givon-Lavi, O. Zamir, and D. Fraser Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers Pediatr Infect Dis J 22 6 2003 532 540
12. D. Bogaert, A. van Belkum, M. Slujter, A. Luijendijk, R. de Groot, and H.C. Rumke Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children Lancet 363 2004 1871 1872
13. K.P. Klugman Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistance Lancet Infect Dis 1 2 2001 85 91
14. D. Bogaert, R. de Groot, and P.W.M. Hermans Streptococcus pneumoniae colonisation: the key to pneumococcal disease Lancet Infect Dis 4 2004 144 154
15. H. Faden, L. Duffy, R. Wasielewski, J. Wolf, D. Krystofk, and Y. Tung Relationship between nasopharyngeal colonization and the development of otitis media in children J Infect Dis 175 1997 1440 1445
16. B.M. Gray, G.M. Converse, and H.C. Dillon Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life J Infect Dis 142 6 1980 923 933
17. Centers for Disease Control and Prevention. Decreased availability of pneumococcal conjugate vaccine. MMWR Morb Mort Wkly Rep 2001;50(36):783.
18. Centers for Disease Control and Prevention. Limited supply of penumococcal conjugate vaccine. MMWR Morb Mort Wkly Rep 2003;52(50):1234.
19. T.W. Hennessy, K.M. Petersen, D. Bruden, A.J. Parkinson, D. Hurlburt, and M. Getty Changes in antibiotic-prescribing practices and carriage of penicillin-resistant Streptococcus pneumoniae: a controlled intervention trial in rural Alaska Clin Infect Dis 34 2002 1543 1550
20. US Department of Health and Human Services NCfHS. The 2003 National Immunization Survey. Hyattsville, MD: Centers for Disease Control and Prevention; 2004.
21. T.W. Hennessy, D. Bruden, K.M. Petersen, A.J. Parkinson, D. Hurlburt, and M. Getty Effect of high-dose amoxicillin on the prevalence of penicillin-resistant Streptococcus pneumoniae in rural Alaska JAMA 287 16 2002 2078 2079
22. M.R. Moore, T.B. Hyde, T.W. Hennessy, D.J. Parks, A.L. Reasonover, and M. Harker-Jones Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska J Infect Dis 190 2004 2031 3038
23. Methods for dilution antimicrobial. Susceptibility tests for bacteria. That grow aerobically; approved standard, 6th ed. CLSI/NCCLS document M7-A6: Clinical and Laboratory Standards Institute/NCCLS, Wayne, PA; 2003 January 2003.
24. Centers for Disease Control and Prevention. Outbreak of invasive pneumococcal disease - Alaska, 2003-2004. Morb Mort Wkly Rep (MMWR) 2005;54(3):72-5.
25. D.G. Perdue, L.R. Bulkow, B.D. Gellin, M. Davidson, K.M. Petersen, and R.J. Singleton Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs JAMA 283 23 2000 3089 3094
26. E.A. Belongia, B.J. Sullivan, P. Chyou, E. Madagame, K.D. Reed, and B. Schwartz A community intervention trial to promote judicious antibiotic use and reduce penicillin-resistant Streptococcus pneumoniae carriage in children Pediatrics 108 2001 757 783
27. H.C. Baggett, T.W. Hennessy, K.M. Rudolph, D. Bruden, A. Reasonover, and A. Parkinson Community-onset methicillin-resistant Staphylococcus aureus associated with antibiotic use and the cytotoxin panton-valentine leukocidin during a furunculosis outbreak in rural Alaska J Infect Dis 189 2004 1565 1573
28. B.J. McMahon, T.W. Hennessy, J.M. Bensler, D.L. Bruden, A.J. Parkinson, and J.M. Morris The relationship among previous antimicrobal use, antimicrobial resistance and treatment outcomes for Helicobacter pylori infections Ann Intern Med 139 6 2003 463 469
29. S.R. Bialek, D.A. Thoroughman, D. Hu, E.P. Simard, J. Chattin, and J. Cheek Hepatitis A incidence and Hepatitis A vaccination among American Indians and Alaska Natives, 1990-2001 Am J Public Health 94 6 2004 996 1001
30. R. Harpaz, B.J. McMahon, H.S. Margolis, C.N. Shapiro, D. Havron, and G. Carpenter Elimination of new chronic Hepatitis B virus infections: results of the Alaska immunization program J Infect Dis 181 2000 413 418
31. R. Singleton, L.R. Bulkow, O.S. Levine, J.C. Butler, T.W. Hennessy, and A. Parkinson Experience with the prevention of invasive Haemophilus influenzae type b disease by vaccination in Alaska: the impact of persistent oropharyngeal carriage J Pediatr 137 3 2000 313 320
32. Alaska Unemployment Rates, 2005: Alaska Department of Labor and Workforce Development; 19 May 2005.
33. K.L. O'Brien, L.H. Moulton, R. Reid, R. Weatherholtz, J. Oski, and L. Brown Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial Lancet 362 2003 355 361
34. K.M. Miernyk, A.J. Parkinson, K.M. Rudolph, L.R. Bulkow, D.P. Greenberg, and J.I. Ward Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska Native and non-Native American children aged <2 years Clin Infect Dis 31 2000 34 41
35. J. Ward, G. Brenneman, G.W. Letson, and W.L. Heyward Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants N Engl J Med 323 20 1990 1393 1401
36. J. Eskola, H. Peltola, A.K. Takala, H. Kayhty, M. Hakulinen, and V. Karanko Efficacy of Haemophilus influenzae type b polysaccharide-diptheria toxoid conjugate vaccine in infancy N Engl J Med 317 1987 717 722
37. Vaccination coverage levels among Alaska Native children aged 19-35 months-National Immunization Survey, United States, 2000-2001. Morb Mort Wkly Rep (MMWR) 2003;52(30):710-2.
38. Continuing Shortage of Pneumococcal Conjugate Vaccine (PCV7) Leads to Revised Recommendations. Anchorage, Alaska: State of Alaska, Department of Health and Social Services; 7 August 2002. Report No. 18.
39. B. Flannery, S.S. Bennett, N. Lynfield, L.H. Harrison, A. Reingold, and P.R. Cieslak Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections JAMA 291 18 2004 2197 2203